Literature DB >> 12871892

Kinetics of SRY gene appearance in maternal serum: detection by real time PCR in early pregnancy after assisted reproductive technique.

J Guibert1, A Benachi, A-G Grebille, P Ernault, J-R Zorn, J-M Costa.   

Abstract

BACKGROUND: Fetal DNA circulating in maternal serum offers a possibility for non-invasive prenatal diagnosis but its kinetics during very early pregnancy is still unclear. In order to clarify this point, the studies on the kinetics of fetal DNA appearance in maternal serum were conducted on patients undergoing assisted reproduction.
METHODS: Using a quantitative real time PCR assay, the presence of SRY gene sequences was evaluated in the serum of patients at the onset of pregnancy.
RESULTS: Twenty-seven patients were originally studied but first trimester abortion occurred in five cases. Among the 22 ongoing pregnancies, ten were found to bear at least one male fetus and all sera from these women gave positive results for SRY gene detection. The SRY gene was found to be detectable as soon as day 18 after embryo transfer in one case and it had been found in the other nine patients by day 37.
CONCLUSIONS: Fetal DNA is found in maternal serum even before the fetal circulation is established, which is highly suggestive that it is released, at least in part, from the trophoblast. Detection of fetal DNA in maternal serum very early in pregnancy may have clinical implications such as with the management of pregnant women carrying a fetus at risk for congenital adrenal hyperplasia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12871892     DOI: 10.1093/humrep/deg320

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  19 in total

Review 1.  Cell-free fetal nucleic acids in amniotic fluid.

Authors:  L Hui; D W Bianchi
Journal:  Hum Reprod Update       Date:  2010-10-05       Impact factor: 15.610

Review 2.  Potential treatments for genetic hearing loss in humans: current conundrums.

Authors:  R Minoda; T Miwa; M Ise; H Takeda
Journal:  Gene Ther       Date:  2015-03-17       Impact factor: 5.250

3.  Evaluation of an Improved Non-invasive Fetal Sex Determination in Haemophilia A Patients.

Authors:  Narmin Mokari-Zadeh; Seyed Alireza Mesbah-Namin
Journal:  J Clin Diagn Res       Date:  2015-07-01

Review 4.  Review: cell-free fetal DNA in the maternal circulation as an indication of placental health and disease.

Authors:  E S Taglauer; L Wilkins-Haug; D W Bianchi
Journal:  Placenta       Date:  2013-12-01       Impact factor: 3.481

Review 5.  Tracking fetal development through molecular analysis of maternal biofluids.

Authors:  Andrea G Edlow; Diana W Bianchi
Journal:  Biochim Biophys Acta       Date:  2012-04-19

6.  Circulating cell-free DNA levels increase variably following chorionic villus sampling.

Authors:  Neeta L Vora; Kirby L Johnson; Inga Peter; Hocine Tighiouart; Steven J Ralston; Sabrina D Craigo; Diana W Bianchi
Journal:  Prenat Diagn       Date:  2010-04       Impact factor: 3.050

Review 7.  Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening.

Authors:  Kathryn J Gray; Louise E Wilkins-Haug
Journal:  Pediatr Radiol       Date:  2018-03-17

8.  Sensitivity of noninvasive prenatal detection of fetal aneuploidy from maternal plasma using shotgun sequencing is limited only by counting statistics.

Authors:  H Christina Fan; Stephen R Quake
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

9.  Development of operational immunologic tolerance with neonatal gene transfer in nonhuman primates: preliminary studies.

Authors:  D S Tai; C Hu; C C I Lee; M Martinez; G Cantero; E H Kim; A F Tarantal; G S Lipshutz
Journal:  Gene Ther       Date:  2015-08-23       Impact factor: 5.250

10.  Non-invasive prenatal diagnosis using cell-free fetal nucleic acids in maternal plasma: Progress overview beyond predictive and personalized diagnosis.

Authors:  Georgia Tounta; Aggeliki Kolialexi; Nikolas Papantoniou; George Th Tsangaris; Emmanuel Kanavakis; Ariadni Mavrou
Journal:  EPMA J       Date:  2011-05-17       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.